These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 32526294)
21. Phospho-Tau Changes in the Human CA1 During Alzheimer's Disease Progression. Regalado-Reyes M; Furcila D; Hernández F; Ávila J; DeFelipe J; León-Espinosa G J Alzheimers Dis; 2019; 69(1):277-288. PubMed ID: 30958368 [TBL] [Abstract][Full Text] [Related]
22. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease. Bondareff W; Harrington CR; Wischik CM; Hauser DL; Roth M J Neuropathol Exp Neurol; 1995 Sep; 54(5):657-63. PubMed ID: 7666054 [TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome. Mondragón-Rodríguez S; Perry G; Luna-Muñoz J; Acevedo-Aquino MC; Williams S Neuropathol Appl Neurobiol; 2014 Feb; 40(2):121-35. PubMed ID: 24033439 [TBL] [Abstract][Full Text] [Related]
24. Truncated tau protein as a new marker for Alzheimer's disease. Novák M Acta Virol; 1994 Jun; 38(3):173-89. PubMed ID: 7817900 [TBL] [Abstract][Full Text] [Related]
25. Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology. Mondragón-Rodríguez S; Mena R; Binder LI; Smith MA; Perry G; García-Sierra F Neuropathol Appl Neurobiol; 2008 Feb; 34(1):62-75. PubMed ID: 17971079 [TBL] [Abstract][Full Text] [Related]
26. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Augustinack JC; Schneider A; Mandelkow EM; Hyman BT Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744 [TBL] [Abstract][Full Text] [Related]
27. Immunological demonstration of tau protein in neurofibrillary tangles of Alzheimer's disease. Brion JP J Alzheimers Dis; 2006; 9(3 Suppl):177-85. PubMed ID: 16914857 [TBL] [Abstract][Full Text] [Related]
28. Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain. Moloney CM; Labuzan SA; Crook JE; Siddiqui H; Castanedes-Casey M; Lachner C; Petersen RC; Duara R; Graff-Radford NR; Dickson DW; Mielke MM; Murray ME Alzheimers Dement; 2023 Mar; 19(3):1029-1040. PubMed ID: 35920592 [TBL] [Abstract][Full Text] [Related]
29. Characterization of thorn-shaped astrocytes in white matter of temporal lobe in Alzheimer's disease brains. López-González I; Carmona M; Blanco R; Luna-Muñoz J; Martínez-Mandonado A; Mena R; Ferrer I Brain Pathol; 2013 Mar; 23(2):144-53. PubMed ID: 22882361 [TBL] [Abstract][Full Text] [Related]
30. Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer's Disease. Hernandes-Alejandro M; Montaño S; Harrington CR; Wischik CM; Salas-Casas A; Cortes-Reynosa P; Pérez Salazar E; Cazares-Apatiga J; Apatiga-Perez R; Ontiveros Torres MÁ; Perry G; Pacheco-Herrero M; Luna-Muñoz J J Alzheimers Dis; 2020; 76(2):553-569. PubMed ID: 32538846 [TBL] [Abstract][Full Text] [Related]
31. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease. Iqbal K; Grundke-Iqbal I Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645 [TBL] [Abstract][Full Text] [Related]
32. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains. Nagamine S; Yamazaki T; Makioka K; Fujita Y; Ikeda M; Takatama M; Okamoto K; Yokoo H; Ikeda Y Neuropathology; 2016 Aug; 36(4):333-45. PubMed ID: 26685795 [TBL] [Abstract][Full Text] [Related]
33. A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain. Ercan-Herbst E; Ehrig J; Schöndorf DC; Behrendt A; Klaus B; Gomez Ramos B; Prat Oriol N; Weber C; Ehrnhoefer DE Acta Neuropathol Commun; 2019 Dec; 7(1):192. PubMed ID: 31796124 [TBL] [Abstract][Full Text] [Related]
34. Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain. Nishimura M; Tomimoto H; Suenaga T; Namba Y; Ikeda K; Akiguchi I; Kimura J Am J Pathol; 1995 May; 146(5):1052-8. PubMed ID: 7747799 [TBL] [Abstract][Full Text] [Related]
35. From tangles to tau protein. Iqbal K; Novak M Bratisl Lek Listy; 2006; 107(9-10):341-2. PubMed ID: 17262984 [TBL] [Abstract][Full Text] [Related]
36. Examination of phosphorylated tau protein as a PHF-precursor at early stage Alzheimer's disease. Lai RY; Gertz HN; Wischik DJ; Xuereb JH; Mukaetova-Ladinska EB; Harrington CR; Edwards PC; Mena R; Paykel ES; Brayne C Neurobiol Aging; 1995; 16(3):433-45. PubMed ID: 7566351 [TBL] [Abstract][Full Text] [Related]
37. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models. Zhang Q; Zhang X; Sun A Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923 [TBL] [Abstract][Full Text] [Related]
38. Hyperspectral Raman imaging of neuritic plaques and neurofibrillary tangles in brain tissue from Alzheimer's disease patients. Michael R; Lenferink A; Vrensen GFJM; Gelpi E; Barraquer RI; Otto C Sci Rep; 2017 Nov; 7(1):15603. PubMed ID: 29142266 [TBL] [Abstract][Full Text] [Related]
39. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models]. Brion JP Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):287-94. PubMed ID: 10992876 [TBL] [Abstract][Full Text] [Related]
40. Alzheimer's disease brain contains tau fractions with differential prion-like activities. Li L; Shi R; Gu J; Tung YC; Zhou Y; Zhou D; Wu R; Chu D; Jin N; Deng K; Xu J; Gong CX; Iqbal K; Liu F Acta Neuropathol Commun; 2021 Feb; 9(1):28. PubMed ID: 33597014 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]